• Skip to primary navigation
  • Skip to main content
  • Skip to footer

LKT Labs

Biochemicals for Life Science Research

  • Products
    • New Products
    • Cancer Biology
    • Cardiovascular
    • Endocrine Signaling and Immunology
    • Metabolic and GI Pathology
    • Microbiology
    • Natural Products
    • Neuroscience
    • Peptides
    • Pharmaceutical Impurities and Derivatives
    • Stem Cell Modulators
  • Services
    • Custom Synthesis
    • Natural Product Isolation
    • Analytical Services
  • Int’l Distributors
  • Support
    • About LKT Labs
    • General Inquiry
    • Bulk Quote Request
    • Document Request
    • Technical Support
    • Catalog Request
    • Product Flyers
  • Contact Us
  • Cart
  • Login / Register
2,5-Di-tert-butyl-4-hydroxyanisole

2,5-Di-tert-butyl-4-hydroxyanisole

Product ID D3575
Cas No. 1991-52-2
Purity ≥98%
Product Unit SizeCostQuantityStock
1 g $46.00 In stock
5 g $129.00 Please Inquire
Bulk Quote

Quicklinks

  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Custom Order

Description

2,5-Di-tert-butyl-4-hydroxyanisole is a phenol. Similar derivatives exhibit antioxidative, cytoprotective, and carcinogenic activities; other similar compounds also inhibit Ca2+ ATPases.

Product Info

Cas No.

1991-52-2

Purity

≥98%

Formula

C15H24O2

Formula Wt.

236.35

IUPAC Name

2,5-ditert-butyl-4-methoxyphenol

Synonym

2,5-di-tert-butyl-4-methoxyphenol

Melting Point

99-102°C

Appearance

White Crystal Powder

Shipping and Storage

Store Temp

4°C

Ship Temp

Ambient

Downloads

MSDS

D3575 MSDS PDF

Info Sheet

D3575 Info Sheet PDF

References

Qu J, Adam J, Bloxham DM, et al. Phosphatidylserine-dependent adhesion of T cells to endothelial cells. Biochim Biophys Acta. 2000 Jun 15;1501(2-3):99-115. PMID: 10838184.

Lam LK, Garg P. Tumorigenicity of di-tert-butyl-substituted hydroquinone and hydroxyanisoles in the forestomach of Syrian golden hamsters. Carcinogenesis. 1991 Jul;12(7):1341-4. PMID: 2070501.

Mizutani T. Protective effects of butylated hydroxyanisole and its analogs on the lung toxicity of butylated hydroxytoluene in mice. Res Commun Chem Pathol Pharmacol. 1985 Oct;50(1):125-33. PMID: 4081305.

Custom Order

  • Size of single unit expressed as number (e.g. '500' in the case of 500 mg)
  • Total quantity of unit size desired (e.g. '10' in the case of 10 x 500 mg). If only one unit is desired, you may leave this blank.
  • This field is for validation purposes and should be left unchanged.

Related Products

  • B3200

    BI-2536

    PLK1 inhibitor.

    ≥98%
  • A0966

    Adrenocorticotropic Hormone (1-16), human

    Endogenous peptide hormone fragment, involved i...

    ≥95%
  • T6803

    Trandolapril

    ACE inhibitor.

    ≥98%
  • C2942

    Mechlorethamine Hydrochloride

    Nitrogen mustard, DNA alkylator.

    ≥98%
  • B165121

    Bedaquiline Fumarate

    Bactericidal

    ≥98%
  • N3213

    Nidulal

    Sesquiterpene found in Nidula.

    ≥95%
  • A2048

    Aflatoxin G1

    Mycotoxin produced by species of Aspergillus; D...

    ≥98%
  • A9617

    Azelnidipine

    Dihydropyridine; L-type Ca2+ channel blocker.

    ≥98%
  • T0299

    Tazobactam Sodium

    β-lactamase inhibitor.

    ≥98%
  • P3469

    Pirfenidone

    Collagen synthesis inhibitor.

    ≥98%
  • G5320

    GNF-2

    Abl inhibitor.

    ≥98%
  • D3431

    3,4-Dihydroxyphenyl Ethanol

    Polyphenol found in olive oil, antioxidant.

    ≥95%
  • B5874

    Bosutinib

    Src and Abl inhibitor.

    ≥98%
  • G6802

    Granisetron Hydrochloride

    5-HT3 antagonist.

    ≥98%
  • E6782

    S-Equol

    Isoflavone, phytoestrogen found in soy; ER agon...

    ≥99%
  • S6247

    Splitomicin

    SIRT1/2 inhibitor.

    ≥98%
  • D3352

    Dinaciclib

    BRD binding agent, CDK1/2/5/9 inhibitor.

    ≥99%
  • D5994

    Doxepin Hydrochloride

    FIASMA, 5-HT1/2, M1-5 mAChR, α1-adrenergic, hi...

    ≥98%
  • T3132

    Thiazovivin

    ROCK inhibitor.

    ≥98%
  • C1613

    Cediranib

    VEGFR inhibitor.

    ≥98%

Footer

  • Contact Us
  • About Us
  • Site Map
  • Terms and Conditions
LKT Laboratories, Inc.
545 Phalen Blvd.
St. Paul MN, 55130

Ph: (888)-558-5227
Fax: (888)-558-7329

©2026 LKT Laboratories, All Rights Reserved - Products for research use only